FDA approves unpopular bivalent Covid booster vaccines for BABIES trends now FDA approves unpopular bivalent Covid shot for BABIES and 'encourages parents to get their child vaccinated before the holidays' By Mansur Shaheen Deputy Health Editor For Dailymail.Com Published: 17:08 GMT, 8 December 2022 | Updated: 17:08 GMT, 8 December 2022 Viewcomments US health officials today approved Pfizer and Moderna's bivalent Covid vaccines for babies, in a move bound to draw criticism. The Food and Drug Administration (FDA) has green-lit plans for the updated shots to be given as part of a three-dose course for children aged six months to four years. Agency officials said they 'encourage parents and caregivers' to get their child vaccinated 'especially as we head into the holidays and winter months'. It comes after a study found the bivalent vaccines are significantly weaker against a rising Covid variant expected to become dominant in the US in months. US health officials today approved Pfizer and Moderna's bivalent Covid vaccines for babies, in a move bound to draw criticism Pre-school-aged children were already allowed to receive three extra-small doses of Pfizer's original Covid vaccine, instead of the standard two-dose regimen for adults The move will see them given the Omicron-specific booster - made by either Pfizer of Moderna - as their third and final shot. FDA Commissioner Robert Califf said: 'More children now have the opportunity to update their protection against COVID-19 with a bivalent COVID-19 vaccine. 'And we encourage parents and caregivers of those eligible to consider doing so – especially as we head into the holidays and winter months where more time will be spent indoors. 'As this virus has changed, and immunity from previous COVID-19 vaccination wanes, the more people who keep up to date on COVID-19 vaccinations, the more benefit there will be for individuals, families and public health by helping prevent severe illnesses, hospitalizations, and deaths.' Share or comment on this article: All rights reserved for this news site (dailymail) and under his responsibility